Respiratory Tract Infections (RTI) Completed Phase 3 Trials for Bevacizumab (DB00112)
Also known as: Infection, Respiratory Tract / Infections, Respiratory Tract / Respiratory tract infections NEC / Respiratory Tract Infection / Recurrent Upper and Lower Respiratory Tract Infections (RTIs) / Respiratory Tract Infections / Infection respiratory / Respiratory infection / Respiratory tract infection (disorder) / Respiratory tract infection NOS / RTI / Unspecified respiratory tract infection
Indication | Status | Phase |
---|---|---|
DBCOND0070409 (Respiratory Tract Infections (RTI)) | Completed | 3 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT04822818 | EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEVĀ®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19 | Treatment |